Related Experiment Video
Updated: May 24, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies
Erasmia Broussalis1, Eugen Trinka, Monika Killer
1Paracelus Medical University Salzburg, Christian-Doppler-Klinik, Department of Neurology, Ignaz-Harrer Strasse 79, 5020 Salzburg, Austria. e.broussalis@salk.at
Abstract:
Stroke still remains a major healthcare problem. The growing understanding of the mechanism of cell death in ischemia leads to new approaches in stroke treatment. The aim of neuroprotection is to reduce the post-stroke impairment and the overall costs that are accompanied in patients with severe disability. Despite encouraging data from experimental animal models, almost all neuroprotective therapies have, to date, not been established in clinical routine. In this part B of our review on stroke therapies we provide an overview on future candidates in stroke therapy and neuroprotective agents that are under investigation.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Venous Thrombosis III: Interprofessional Care
